3-Cyano-7-ethoxycoumarin

CAS No. 117620-77-6

3-Cyano-7-ethoxycoumarin( —— )

Catalog No. M20911 CAS No. 117620-77-6

3-Cyano-7-ethoxycoumarin is cytochrome P450 (CYP) isoforms CYP1A1 and CYP1A2 .

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 28 In Stock
25MG 36 In Stock
50MG 58 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    3-Cyano-7-ethoxycoumarin
  • Note
    Research use only, not for human use.
  • Brief Description
    3-Cyano-7-ethoxycoumarin is cytochrome P450 (CYP) isoforms CYP1A1 and CYP1A2 .
  • Description
    3-Cyano-7-ethoxycoumarin is cytochrome P450 (CYP) isoforms CYP1A1 and CYP1A2 .
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    117620-77-6
  • Formula Weight
    215.2
  • Molecular Formula
    C12H9NO3
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:16.5 mg/mL (76.67 mM)
  • SMILES
    CCOc1ccc2cc(C#N)c(=O)oc2c1
  • Chemical Name
    3-Cyano-7-ethoxycoumarin

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.White I N H . A continuous fluorometric assay for cytochrome P-450-dependent mixed function oxidases using 3-cyano-7-ethoxycoumarin[J]. Analytical Biochemistry 1988 172(2):304-310.
molnova catalog
related products
  • SNAP-25 187-203

    This amino acids187 to 203 fragment is derived from the C-terminal helix of synaptosomal-associated protein of 25 kDa (SNAP-25). This peptide is able to rescue exocytosis from botulinum neurotoxin E (BoNT/E)-treated cells, albeit at higher concentrations than the full-length coil.

  • HPPH

    HPPH (Photochlor) is a second-generation photosensitizer. It is used as photodynamic therapy (PDT) agent.

  • Salnacedin

    Salnacedin (G-201) is a small molecule compound used in the treatment of immune system disorders, skin and musculoskeletal disorders, and can be used in studies of acne vulgaris, dermatitis and psoriasis.